Explore UAB

Colleges & Schools

UAB Reporter News and Information for the UAB Community
April 30, 2024 Manage Listing

Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared with Semaglutide Once Weekly in Adult Participants with Type 2 Diabetes

A Phase 3, Randomized, Multicenter, Open-label Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared with Semaglutide Once Weekly in Adult Participants with Type 2 Diabetes and Inadequate Glycemic Control with Metformin with or without SGLT2 Inhibitor (TRANSCEND-T2D-2)

TRANSCEND-T2D-2 is a clinical research study for people with type 2 diabetes.
This study will test if an investigational medicine (the medicine being studied) can
help with blood glucose (sugar) and weight management compared with an existing
treatment for type 2 diabetes.

  • Are aged 18 years or older
  • Have type 2 diabetes
  • Have been taking 1500mg or more of metformin each day for at least 3 months (with or without SGLT2i)
  • Have a BMI of 25 or more
  • Have HbA1c levels of 7.0% to 10.5%

To see if you qualify please contact at 205-996-4015, 205-934-5564 or via mail at This email address is being protected from spambots. You need JavaScript enabled to view it. or This email address is being protected from spambots. You need JavaScript enabled to view it.

Looking for other studies?

ResearchMatch is a multi-institution project that pairs volunteers with researchers seeking study participants.

Back to Top